A detailed history of Ogorek Anthony Joseph transactions in Becton Dickinson & CO stock. As of the latest transaction made, Ogorek Anthony Joseph holds 128 shares of BDX stock, worth $29,246. This represents 0.01% of its overall portfolio holdings.

Number of Shares
128
Previous 127 0.79%
Holding current value
$29,246
Previous $29,000 3.45%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$221.47 - $242.41 $221 - $242
1 Added 0.79%
128 $30,000
Q1 2024

May 03, 2024

BUY
$233.45 - $247.73 $4,669 - $4,954
20 Added 18.69%
127 $31,000
Q3 2020

Nov 02, 2020

SELL
$215.77 - $276.76 $10,788 - $13,838
-50 Reduced 31.85%
107 $24,000
Q2 2020

Aug 07, 2020

SELL
$219.9 - $263.41 $3,298 - $3,951
-15 Reduced 8.72%
157 $38,000
Q2 2019

Jul 15, 2019

BUY
$217.4 - $246.08 $4,348 - $4,921
20 Added 13.16%
172 $43,000
Q3 2018

Oct 17, 2018

BUY
$233.07 - $256.0 $10,488 - $11,520
45 Added 42.06%
152 $39,000
Q1 2018

Apr 18, 2018

BUY
$205.46 - $240.27 $7,396 - $8,649
36 Added 50.7%
107 $23,000
Q4 2017

Jan 22, 2018

BUY
$189.0 - $222.64 $13,419 - $15,807
71
71 $15,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Ogorek Anthony Joseph Portfolio

Follow Ogorek Anthony Joseph and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ogorek Anthony Joseph , based on Form 13F filings with the SEC.

News

Stay updated on Ogorek Anthony Joseph with notifications on news.